Clot Care Images
DVT Awareness | Join Our Email List | Thursday, September 09, 2010

Postings on Exanta

For Patients and Caregivers

Posting Date Posted
AstraZeneca Decides to Withdraw Exanta February, 2006
FDA Rejects Ximelagatran (brand name Exanta) October, 2004
Understanding Atrial Fibrillation

Frequently Asked Questions Date Posted
What is the d-Dimer test? August, 2006
Will the blood clot in my leg go away now that I am on medication for it? October, 2005

For Health Care Providers

Posting Date Posted
Can better INR control be achieved, and if so, how will new anticoagulants compare to warfarin (Coumadin)? March, 2007
Update on Treatment and Prevention of Pulmonary Embolism August, 2006
Is it safe to omit additional tests is d-Dimer is negative? August, 2006
AstraZeneca Decides to Withdraw Exanta February, 2006
What Happened to Ximelagatran? March, 2005
FDA Rejects Ximelagatran (brand name Exanta) October, 2004
DVTs Eliminated in Total Hip or Knee Replacement Surgery? October, 2004
Exanta not Recommended by FDA Advisory Panel, Causes M.I.s? September, 2004
New Supplement Devoted to Factor Xa Inhibitors (fondaparinux) August, 2004
Anticoagulation in Special Populations August, 2004
An Overview of Anticoagulants, Antiplatelet Agents, and the Combination in Patients with Mechanical Heart Valves May, 2004
Ximelagatran (brand name Exanta) is Leading the Coming Revolution in Stroke Prevention in Atrial Fibrillation -- Two New Studies January, 2004

Copyright 2000-2010 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to webmaster@clotcare.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.